Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Other Gross PP&E Adjustments (2021 - 2026)

bioAffinity Technologies has reported Other Gross PP&E Adjustments over the past 6 years, most recently at -$387321.0 for Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 11.73% to -$387321.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$387321.0 through Mar 2026, up 11.73% year-over-year, with the annual reading at -$552695.0 for FY2025, 12.29% up from the prior year.
  • Other Gross PP&E Adjustments was -$387321.0 for Q1 2026 at bioAffinity Technologies, up from -$552695.0 in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $384113.0 in Q1 2023 and troughed at -$787732.0 in Q4 2023.
  • The 5-year median for Other Gross PP&E Adjustments is -$413975.0 (2023), against an average of -$226422.3.
  • Year-over-year, Other Gross PP&E Adjustments crashed 12102.62% in 2023 and then skyrocketed 165.85% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $6563.0 in 2022, then crashed by 12102.62% to -$787732.0 in 2023, then rose by 20.01% to -$630106.0 in 2024, then increased by 12.29% to -$552695.0 in 2025, then grew by 29.92% to -$387321.0 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Other Gross PP&E Adjustments are -$387321.0 (Q1 2026), -$552695.0 (Q4 2025), and $263095.0 (Q3 2025).